CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
January 20, 2022
ATRA plus LD-RTX for ITP
CME
Blood (2022) 139 (3): 467.
Article history
Submitted:
December 3, 2021
Accepted:
December 3, 2021
Connected Content
A related article has been published:
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP
Citation
ATRA plus LD-RTX for ITP. Blood 2022; 139 (3): 467. doi: https://doi.org/10.1182/blood.2021015069
Download citation file: